drugset / Trial / NCT00212667

Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan

NCT00212667

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.

Timeline

Start
2002-08
Primary completion
2006-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Minodronic acid Small molecule 1 mg Oral

Indications